The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 28, 2021
Filed:
Mar. 03, 2020
Applicant:
Janssen Pharmaceutica NV, Beerse, BE;
Inventors:
Christa C. Chrovian, La Jolla, CA (US);
Michael A. Letavic, San Diego, CA (US);
Jason C. Rech, Ann Arbor, MI (US);
Dale A. Rudolph, San Diego, CA (US);
Akinola Soyode-Johnson, San Diego, CA (US);
Brice M. Stenne, La Jolla, CA (US);
Jessica L. Wall, San Diego, CA (US);
Assignee:
JANSSEN PHARMACEUTICA NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4188 (2006.01); A61P 25/24 (2006.01); A61K 31/12 (2006.01); C07D 401/02 (2006.01); C07D 205/02 (2006.01); C07D 207/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4188 (2013.01); A61K 31/12 (2013.01); A61P 25/24 (2018.01); C07D 401/02 (2013.01); C07D 205/02 (2013.01); C07D 207/08 (2013.01);
Abstract
Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.